Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance.

作者: G. Midhagen , A.-K. Aberg , P. Olcen , G. Jarnerot , T. Valdimarsson

DOI: 10.1111/J.1365-2796.2004.01406.X

关键词:

摘要: Coeliac disease (CD) is considered to be the result of a complex interplay intrinsic (genetic) factors and variable extrinsic (environmental) factors. The background CD explains its wide spectrum clinical manifestations. For very long time was more or less childhood, which extremely rare in adults. Nowadays we know that one most common food intolerance disorders. An epidemiological study geographically defined area Sweden (Paper1) showed prevalence 95.5/ 100 000 inhabitants. Among associated diseases an especially high incidence thyroid disease, 10.8% observed. In fifteen-year cohort follow up all CD-patients residing counties Orebro Linkoping (Paper 2) total mortality increased with 38% (SMR 1.38 95% C.I. 0.31-0.83). This mainly explained by 48% death rate ischemic heart significant patients over 65 years 1.58 1.00-2.06). However, there 47 % lower risk malignancies (SIR 0.53 A 22 consecutively biopsy-proven adult 3), were followed respect antibody titres from diagnosis after 1, 3, 6, 12 months on gluten free diet (GFD). All fell sharply within month. Thus excluding serologically patient who has initiated GFD herself not recommend. another IV) diagnosed 8-12 earlier recommended recommended, reliability history, serological biochemical markers predict appearance small intestinal mucosa analysed IV). history strict gave predictive value 88% remission. values tests (AGA, EmA tTG) remission 93% for all. gastro-intestinal symptoms evaluated GSRS questionnaire. Subjects reported significantly GI-symptoms than general population sample (p<0.01). particularly true women scored worse female controls .By contrast men no male controls.

参考文章(40)
Maria Fotoulaki, Clinical application of immunological markers as monitoring tests in celiac disease. Digestive Diseases and Sciences. ,vol. 44, pp. 2133- 2138 ,(1999) , 10.1023/A:1026651224985
Kouroche Vahedi, Francoise Mascart, Jean-Yves Mary, Jean-Eric Laberenne, Yoram Bouhnik, Marie-Christine Morin, Annick Ocmant, Christine Velly, Jean-Frederic Colombel, Claude Matuchansky, Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. The American Journal of Gastroenterology. ,vol. 98, pp. 1079- 1087 ,(2003) , 10.1111/J.1572-0241.2003.07284.X
M. Mylotte, B. Egan-Mitchell, C. F. McCarthy, B. McNicholl, Incidence of Coeliac Disease in the West of Ireland BMJ. ,vol. 1, pp. 703- 705 ,(1973) , 10.1136/BMJ.1.5855.703
Jan Hed, Gudrun Lieden, Ewa Ottosson, Magnus Ström, Anders Walan, Ove Groth, Florence Sjögren, Lennart Franzen, IgA ANTI-GLIADIN ANTIBODIES AND JEJUNAL MUCOSAL LESIONS IN HEALTHY BLOOD DONORS The Lancet. ,vol. 328, pp. 215- 215 ,(1986) , 10.1016/S0140-6736(86)92508-0
Maria Grazia Clemente, Maria Paola Musu, Fulvia Frau, Cicotto Lucia, Stefano De Virgiliis, Antitissue transglutaminase antibodies outside celiac disease. Journal of Pediatric Gastroenterology and Nutrition. ,vol. 34, pp. 31- 34 ,(2002) , 10.1097/00005176-200201000-00008
Oivi Uibo, R. Uibo, V. Kleimola, T. J�gi, M. M�ki, Serum IgA anti-gliadin antibodies in an adult population sample. High prevalence without celiac disease. Digestive Diseases and Sciences. ,vol. 38, pp. 2034- 2037 ,(1993) , 10.1007/BF01297081
TADEUSZ P. CHORZELSKI, JADWIGA SULEJ, HANNA TCHORZEWSKA, STEFANIA JABLONSKA, ERNST H. BEUTNER, VIJAY KUMAR, IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Annals of the New York Academy of Sciences. ,vol. 420, pp. 325- 334 ,(1983) , 10.1111/J.1749-6632.1983.TB22220.X
U Volta, M Lenzi, R Lazzari, F Cassani, A Collina, F B Bianchi, E Pisi, Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut. ,vol. 26, pp. 667- 671 ,(1985) , 10.1136/GUT.26.7.667